Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS)

Exclusion Criteria

• •1. Subjects who have been prescribed any other formulation (i.e., oral suspension) or dose regimen of oseltamivir, or any other antiviral medication for the treatment of influenza
• •2. Individuals presenting at the pharmacy with an oseltamivir prescription who themselves do not currently have a diagnosis of influenza (e.g., individuals filling a prescription for someone else who is currently infected with influenza; individuals filling a prescription that they or someone else will use for prevention of influenza infection or for treatment of a future influenza infection)
• •3. Subjects who have received an oseltamivir prescription from a physician participating in the study
• •4. Subjects for whom the oseltamivir prescription is not filled for any reason
• •5. Subjects who, in the opinion of research personnel, will not comply with the study procedures
• •6. Staff in the pharmacy or the primary care clinic who are involved in the study, and their family members
• •1. Subjects who have already started treatment with an antiviral medication for their current influenza symptoms
• •2. Subjects for whom the oseltamivir prescription is not filled for any reason
• •3. Subjects who, in the opinion of the investigator, are not suitable for the study for clinical or other reasons (e.g., the patient requires hospitalisation or will not be able to comply with study procedures)
• •4. Staff in the pharmacy or the primary care clinic who are involved in the study, and their family members